Stock report · Delisted · Nasdaq
NanoVibronix Inc (NAOV)
3.87USD Delisted Final close · Dec 15, 2025
NAOV no longer trades. NanoVibronix was delisted from the Nasdaq in December 2025.
All prices on this page are historical. The last trade was on December 15, 2025, at $3.87.
NAOV stock price history
Final trading statistics
- Final close
- $3.87
- Final trading day
- Dec 15, 2025
- Market cap at delisting
- $4.21M
- Shares outstanding
- 1.09M
- Final 52-week range
- $0.20 – $17.40
- Avg. volume (final 3 mo.)
- 115,516
- All-time high
- $16104.00 · Oct 2017
- All-time low
- $3.74 · Nov 2025
- Return since IPO
- -99.9%
- Beta
- 2.06
- Book value / share
- $42.00
- Price / book
- 0.09
About NanoVibronix Inc
NanoVibronix, Inc. worked through subsidiaries on non-invasive devices that trigger biological responses. Its targets were biofilm prevention, pain therapy and wound healing, with devices meant for home use without a medical professional.
UroShield used ultrasound to help keep bacteria and biofilm out of urinary catheters, improve antibiotic performance and ease catheter discomfort; UroShield Ultra served a similar purpose. PainShield, PainShield MD (single patch) and PainShield Plus (dual patch) used therapeutic ultrasound for pain, muscle spasm and joint contractures. WoundShield was a patch device meant to support tissue regrowth and wound healing.
The company sold directly to patients and through distributors in the United States, Europe, Australia, Israel, New Zealand and elsewhere. It was incorporated in 2003 and based in Tyler, Texas. The stock was delisted from the Nasdaq in December 2025, with the last trade on December 15, 2025 at $3.87.
- Exchange (former)
- Nasdaq
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Tyler, TX
- Employees
- 31
- IPO date
- June 27, 2017
- Delisted
- December 15, 2025
- SEC CIK
- 1326706
NanoVibronix financials before the delisting
The last 5 fiscal years NanoVibronix reported as a public company, fiscal year ending December.
NAOV revenue and net income
NAOV earnings per share
NAOV annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $2.56M | −$3.7M | −$5.05 |
| FY2023 | $2.28M | −$3.7M | −$45.44 |
| FY2022 | $752.0K | −$5.4M | −$4.04 |
| FY2021 | $1.70M | −$14.3M | −$0.48 |
| FY2020 | $623.0K | −$4.3M | −$0.62 |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
NanoVibronix stock FAQ
What happened to NanoVibronix stock?
NanoVibronix was delisted from the Nasdaq in December 2025. The final close was $3.87 on December 15, 2025.
Can I still buy NAOV stock?
No. NAOV is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on December 15, 2025.
What was the last price of NAOV?
NAOV last closed at $3.87 on December 15, 2025, which valued the company at about $4.21M.
How did NanoVibronix do in its last full fiscal year?
In fiscal 2024, its last full year as a public company, NanoVibronix reported revenue of $2.56M and net income of −$3.7M.
When did NanoVibronix go public?
NanoVibronix shares started trading on June 27, 2017.
NAOV no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.